Natuzzi S.p.A.: Shareholder Letter and Financial Results
2021 – FOURTH QUARTER AND FISCAL YEAR RESULTS FOURTH QUARTER 2021 HIGHLIGHTS INVOICED SALES INCREASED…
News
Medical Fish-Skin Company Kerecis Introduces MariGen Expanse at the SAWC Conference
An economic solution for large wounds treated in the out-patient care setting PHOENIX–(BUSINESS WIRE)–#SAWC–Kerecis®, the…
First Bancorp to Announce 1Q 2022 Results on April 28, 2022
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–First BanCorp (the “Corporation”) (NYSE: FBP), the bank holding company for…
BlackRock TCP Capital Corp. to Report First Quarter 2022 Financial Results on May 4, 2022
SANTA MONICA, Calif.–(BUSINESS WIRE)–BlackRock TCP Capital Corp. (NASDAQ: TCPC) announced today that it will report…
Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Highlights
Highlights Include Company’s Progress in the Following Areas: Advances in the Research, Development, and Manufacturing…
Exscientia Presents Three Posters Demonstrating Potential of Precision Medicine Platform in Drug Discovery at the American Association of Cancer Research Annual Meeting 2022
OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today shared details of its participation…
Orchid Island Capital to Announce First Quarter 2022 Results
VERO BEACH, Fla.–(BUSINESS WIRE)–Orchid Island Capital, Inc. (NYSE:ORC) (“Orchid” or the “Company”), a real estate…
Negro Leagues Baseball Museum and First Business Bank Announce Partnership to Help “Coin the Legacy” of the Negro Leagues
The partnership includes designation as the “Official Bank” of the first-ever United States Mint Negro…
Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at AACR Annual Meeting 2022
SOUTH SAN FRANCISCO, Calif., April 08, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
Coherus and Junshi Biosciences Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting
– Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and…
Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors
The recommended phase 2 dose was determined at 480 mg AFM24 has demonstrated a well-managed…
Aadi Bioscience Announces Data Presentation on incidence of TSC1 and TSC2 Alterations in Advanced Cancers at the Annual Meeting of the American Association for Cancer Research (AACR)
– First rigorous analysis estimates TSC1 and TSC2 definite impact alteration incidence in U.S. as…
Adagene Presents Data Demonstrating First and Best-in-Class Potential for Differentiated Preclinical Antibody Candidates at American Association for Cancer Research (AACR) Annual Meeting 2022
– Poster presentations showcase SAFEbody® precision masking technology applicability across targets and modalities – –…
Kronos Bio Presents Preclinical Data on Oral CDK9 Inhibitor KB-0742, Providing Additional Evidence of Potential Efficacy in MYC-Amplified and Transcriptionally Addicted Tumors at AACR
Preclinical data featured in three posters show potential of KB-0742 in triple-negative breast, lung and…
Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting
– Data highlight PYX-106’s differentiated activity profile and antitumor activity in an in vivo mouse…
Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American Association for Cancer Research (AACR) Annual Meeting 2022
VIP152 demonstrates antitumor responses in preclinical models of gynecologic malignancies Preliminary monotherapy clinical results presented…
X4 Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022
BOSTON, April 08, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in…
BlueSphere Bio Presents New Data Supporting the Potential of its TCXpress™ Platform at the 2022 AACR Meeting
TCXpress™ identified a diverse set of novel T-cell receptors (TCRs) with in vitro reactivity against…
Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022
GEN-011 shows consistent pattern of activity in first five heavily pre-treated, checkpoint-refractory patients with…
Araris Biotech AG Presents Preclinical Data Highlighting Anti-CD79b ADC Program and Late-Breaking Data on Nectin-4 ADC at the American Association for Cancer Research (AACR) 2022 Annual Meeting
ZURICH, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering a…